No Irregularities in Safadurjung, RML and LHMC: MOS health tells parliament

Published On 2018-03-27 10:19 GMT   |   Update On 2018-03-27 10:19 GMT

 New Delhi: Recently, through a written reply to a question in Lok Sabha, minister of state ( independent charge)  Sh Ashwini Kumar Choubey informed about the Irregularities in Government Hospitals.As far as three Central Government Hospitals i.e. Safdarjung Hospital, Dr. Ram Manohar Lohia Hospital and Lady Hardinge Medical College & Associated Hospitals are concerned, these hospitals...

Login or Register to read the full article
 New Delhi: Recently, through a written reply to a question in Lok Sabha, minister of state ( independent charge)  Sh Ashwini Kumar Choubey informed about the Irregularities in Government Hospitals.

As far as three Central Government Hospitals i.e. Safdarjung Hospital, Dr. Ram Manohar Lohia Hospital and Lady Hardinge Medical College & Associated Hospitals are concerned, these hospitals are procuring the medicines and equipments by calling open tender as per General Financial Rule (GFR) -2017 & Government of India (GOI) guidelines.

In so far as three Central Government Hospitals i.e. Safdarjung Hospital, Dr. Ram Manohar Lohia Hospital and Lady Hardinge Medical College & Associated Hospitals are concerned, no such irregularities and sub-standard purchase of medicines, injections and cannulas in these hospitals at exorbitant rates violating the established procedures and guidelines has been reported.

However, following safeguards are in place to curb such malpractices by these hospitals:-

  1. Procurement is being done as per GFR.

  2. Inspection of items received is being carried out by a Committee constituted by the concerned Hospital.

  3. Lab report of Drugs is being taken on regular basis.


 

 
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News